Skip to main content
Torrent Pharmaceuticals Ltd. logo

Torrent Pharmaceuticals Ltd. — Investor Relations & Filings

Ticker · TORNTPHARM ISIN · INE685A01028 LEI · 335800NA6HK275RIJE13 BSE.NS Manufacturing
Filings indexed 1,762 across all filing types
Latest filing 2024-05-24 Regulatory Filings
Country IN India
Listing BSE.NS TORNTPHARM

About Torrent Pharmaceuticals Ltd.

https://www.torrentpharma.com

Torrent Pharmaceuticals Ltd. is a research-driven organization focused on the development, manufacturing, and marketing of generic formulations. The company holds a significant position in therapeutic areas such as cardiovascular, central nervous system, gastrointestinal, diabetology, and anti-infective treatments. It has strategically expanded its portfolio into dermatology, nephrology, and pain management through targeted acquisitions. The firm operates across multiple international markets, supported by advanced research and development centers and manufacturing facilities that adhere to global regulatory standards. Its core operations prioritize chronic therapy leadership and the provision of high-quality healthcare solutions through a robust pipeline of generic and value-added medicines.

Recent filings

Filing Released Lang Actions
Results
Regulatory Filings
2024-05-24 English
Financial Result Updates
Regulatory Filings
2024-05-24 English
Loss of Share Certificates
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges (BSE and NSE) regarding the loss of a share certificate by a shareholder. It references Regulation 39 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to share certificate loss and related disclosures. The content is about notifying the exchanges and requesting them to inform trading members to refrain from trading the lost shares until duplicates are issued. There is no financial data, earnings information, management discussion, or report attached or referenced as being published. The document is a regulatory notification about share certificate loss, which fits best under Regulatory Filings (RNS) as it is a compliance-related announcement that does not fit other specific categories.
2024-05-21 English
Intimation of Loss of share certificate
Regulatory Filings
2024-05-21 English
Annual Secretarial Compliance Report for the year ended 31-Mar-24
Regulatory Filings
2024-05-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a letter addressed to the stock exchange listing department announcing a post quarterly financial result conference call scheduled for May 24, 2024, to discuss the financial performance for the quarter and year ended March 31, 2024. It provides dial-in details for the call but does not contain any financial data or results itself. The document length is short (2147 characters) and serves as an announcement of an upcoming event rather than the actual report or transcript. Therefore, it is not an Interim/Quarterly Report (IR) or Call Transcript (CT), but rather a Regulatory Filing (RNS) announcing the conference call event.
2024-05-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.